Qualisure Diagnostics Inc. and Protean BioDiagnostics Inc. together will perform the technical validation essential to launch Thyroid GuidePx™ as a Laboratory Developed Test in the United States. Protean BioDiagnostics is a CAP/CLIA certified lab focused on Precision Oncology. Protean’s commitment to deploying the latest and highest quality laboratory diagnostic tools to guide oncology care is congruent with Qualisure’s mission to create tests that address unmet needs in oncology. Protean will play a critical role in paving a path to market in the U.S.